Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes
This rapid pace of innovation will not only provide more effective, needle-free choices but also increase competition in the market, which could eventually lead to better access and more personalized treatment plans for everyone
Rybelsus is unique because it is the only form of semaglutide available as an oral tablet, not a shot
But as we get older, NAD+ levels naturally decline leading to fatigue, brain fog, and slower recovery
At Highland Longevity, we combine compounded tirzepatide with DEXA scans to track objective clinical markers during your care
Here, selenium supplementation not only increased serum selenium and SELENOP concentrations, but also GPx3 activity at Day 4 (Fig